Aardvark Therapeutics, Inc. Liquidation Value
AARD
Other
Cash & Equivalents
$47.05M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $47.05M
Total Obligations: -$10.99M
$36.06M
Per share: $1.65
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $47.05M
AR: $0
Total Obligations: -$10.99M
$36.06M
Per share: $1.65
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $47.05M
AR: $0
Inventory: $0
Total Obligations: -$10.99M
$36.06M
Per share: $1.65
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $36.06M | $1.65 |
| Liquid Liquidation Value | $36.06M | $1.65 |
| Operating Liquidation Value | $36.06M | $1.65 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $47.05M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $10.55M |
| Long-term Debt | N/A |
| Op. Lease Liability | $441,000 |
| Finance Lease | N/A |
| Shares Outstanding | 21.8M |
Explore all 142 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $47.05M | N/A | N/A | $2.07M | $10.55M | N/A | $441,000 | N/A |
| 2025-09-30 | $39.28M | N/A | N/A | $4.44M | $10.74M | N/A | $545,000 | N/A |
| 2025-06-30 | $26.00M | N/A | N/A | $5.06M | $10.31M | N/A | $645,000 | N/A |
| 2025-03-31 | $26.50M | N/A | N/A | $2.56M | $5.98M | N/A | $726,000 | N/A |
▼ Community Notes